Viokase-V:
- Treats exocrine pancreatic insufficiency
- Available in powder and tablet form
- Approved by the FDA for both cats and dogs
Viokase-V is activated whole raw porcine pancreas
for use as replacement therapy in cases of exocrine pancreatic insufficiency.
Based on in vitro evidence, each tablet contains enough pancreatic enzymes
to digest 57 g protein, 33 g fat, and 64 g starch, and each teaspoonful
of powder contains enough to digest 388 g protein, 260 g fat, and 460
g starch.
Viokase-V is available as a powder in 4 oz, 8 oz,
and 12-oz containers. The supplement is also available as a 425 mg tablet
in 500-count bottles.
Viokase-V Tablet Ingredients (per
tablet): Lipase 9,000 USP units, Protease
57,000 USP units, Amylase 64,000 USP units
Viokase-V Powder Ingredients (per
1 tsp or 2.8 gm): Lipase 71,400 USP units, Protease
388,000 USP units, Amylase 460,000 USP units
Warnings:
Keep this product out of reach of children and animals.
Do not use or store in or near open flame or heat.
Viokase-V is intended for use in cats and dogs only.
Do not give to other animals or to humans.
CAUTION: Consult your veterinarian if
your animal's symptoms worsen or fail to improve during treatment with
Viokase-V.
Do not use in animals with a known sensitivity to
any ingredient in this product.
Although this supplement is not usually associated
with side effects, report any change in your pet's health or behavior
to your veterinarian.
Tell your veterinarian about any drugs or supplements
your pet is taking before beginning therapy with Viokase-V.
Warranty and Manufacturer Information:
Fort Dodge Animal Health, Fort Dodge, Iowa 50501
USA
91206
Rev. May 1996
5300E
NAC No.: 10032581